PD-1 INHIBITOR

Clinical trials for PD-1 INHIBITOR explained in plain language.

Never miss a new study

Get alerted when new PD-1 INHIBITOR trials appear

Sign up with your email to follow new studies for PD-1 INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

Immunotherapy combo aims to boost survival in tough head & neck cancer

Disease control Ongoing

This study is testing whether adding an immunotherapy drug (a PD-1 inhibitor) to standard chemotherapy before a patient's main cancer treatment can help people with advanced nasopharyngeal cancer live longer without their cancer returning. It involves 150 participants who are ran…

Matched conditions: PD-1 INHIBITOR

Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control

Last updated Mar 17, 2026 13:10 UTC

PD-1 INHIBITOR

Get alerted when new PD-1 INHIBITOR trials appear

Immunotherapy combo aims to boost survival in tough head & neck cancer